Background. This report describes the in-hospital experience with percutaneous transluminal coronary angioplasty (PTCA) for the state of California in 1989. Data are derived from the statewide hospital discharge abstracts.
P ercutaneous transluminal coronary angioplasty (PTCA) was first performed in humans by Gruentzig in 1977.1 Growth in the ensuing years has been rapid, such that the number of angioplasties performed approximates the number of coronary artery bypass graft (CABG) procedures in the United States.2 Initially PTCA was used for single-vessel stenoses in patients with angina. More recently, multivessel procedures have increased in number, and angioplasty has been applied as a direct or initial therapy for patients with acute myocardial infarction (AMI).
A large number of reports have described the clinical utility of the procedure and detailed short-term and long-term results and complications and variables important in predicting these outcomes.3-'1 However, these reports generally represent the experience of selected institutions or, in a few cases, multi-institutional registries or trials. Whether the results reported from these selected, generally high-volume centers have been achieved for patients at large has not been well defined and serves as the focus of this report. Specifically, we asked whether a statewide experience was comparable to the results reported in the literature and what factors were associated with adverse outcomes. We also addressed the issue of whether hospitals met the published guidelines for minimal institutional caseloads and whether institutional volumes affected outcomes.'2 Herein we report, using administrative hospital discharge abstract data, on all coronary angioplasty procedures performed in nonfederal hospitals in the state of California in 1989.
Methods
Magnetic tapes containing all acute-care hospital patient discharges for the calendar year 1989 from the state of California were obtained from the Office of Statewide Health Planning and Development. This was the most recent year for which data were available when the study was begun. Federal hospitals are excluded from this data set. These data include demographics (age, sex, race), hospital facility identification, the length of stay, up to 25 procedures, and the timing of the procedure relative to admission date. Each record includes one principal diagnosis defined as the "condition established, after study, to be chiefly responsible for occasioning the admission of the patient to the hospital" and up to 24 other secondary diagnoses. 13 Diagnoses are coded according to the International Classification of Diseases: Clinical Modification, Ninth Revision (ICD-9-CM).14 All patients aged 18 years and over who had an ICD-9-CM code for coronary angioplasty were identified (code 36.01, single-vessel PTCA; 36.02, singlevessel angioplasty with infusion of thrombolytic agent; and 36.05, multiple-vessel PTCA with or without thrombolytic agent). We report only on the number of vessels dilated per procedure; the total number of diseased vessels present per patient is not recorded. These cases represent both first PTCAs and repeat PTCAs; we could not identify patients who had undergone revascularization (either PTCA or CABG surgery) before the index hospitalization. Of the 24 951 cases so selected, 24 883 were retained for this data set who also had at least one cardiovascular diagnosis coded. The other 68 cases (0.3%) were excluded because of concern that they might not be cardiac angioplasties. CABG surgery performed on the same or any day after PTCA during the admission was identified.
Because most clinical series have reported results for either patients with angina or AMI but not both, we analyzed both the entire cohort of patients as well as two subgroups based on the presence or absence of a principal diagnosis of AMI. Additionally, we subdivided patients with a principal diagnosis of AMI into those undergoing PTCA on day 0 or day 1 after admission to best identify the group that had PTCA performed as part of the therapy for AMI per se (either as "direct" therapy or as "rescue" therapy with or without associated thrombolytic therapy), in contradistinction to patients in whom PTCA was performed several days after AMI. Days 0 and 1 were combined to include those patients presenting late in the day whose procedure, if performed after midnight, would be coded as having occurred on the day after admission. The division of day 0/1 or later was based on pilot analyses of the 1988 data set, which showed that about a quarter of patients with the principal diagnosis of AMI did not undergo PTCA on day 0 or 1. These cases presumably represented a biologically distinct group having PTCA in the periinfarction period but not as principal therapy for the myocardial infarction. The administration of thrombolytic therapy is not generally coded and its use in AMI in this data set is unknown.
Complications of PTCA as such are not coded in this administrative data set. Patients having AMI as a complication of PTCA cannot be distinguished from those having de novo myocardial infarction that was not the cause of admission, although all such complications should be coded as "other" or secondary diagnoses. For this reason, secondary myocardial infarction diagnoses were not considered further. Subsequent references to AMI refer only to those cases in which AMI was the principal diagnosis. CABG occurring after PTCA is generally a complication or undesired result, although its definition as emergent or elective per se is not available in this data set. However, we did categorize the number of elapsed days between PTCA and CABG surgery so that the timing of surgery could be used to estimate its urgency. The relations between clinical, demographic, or institutional caseload variables and adverse outcomes were tested with bivariate analysis using x2 or contingency table testing for trends. 15 Logistic regression using CABG surgery and, in a separate analysis, mortality as dependent variables was performed for the AMI group and the group without infarction. This employed the variables noted in Table 1 and the timing of the PTCA after admission except that congestive heart failure (CHF) was excluded because it was impossible to ascertain whether it was present before the procedure, and old myocardial infarction was excluded because it appeared to be undercoded (old myocardial infarction was coded in only 3.4% of patients in the AMI group). Goodness of fit for the logistic regression was ascertained by a method similar to that of Hosmer and Lemeshow. 16 Results As illustrated in Table 1 , PTCAs in California are principally performed in men (70.2%); the mean age was 62 years, and 25% of the patients were over 70 years of age. Most of the patients treated were Caucasian (84%). AMI was the principal diagnosis in 19%, and in the non-myocardial infarction group, 95% had a principal diagnosis of angina. Most procedures (87%) were identified as single-vessel PTCAs.
Mortality
In-hospital mortality was 1.4% overall. As shown in Table 2 , principal or secondary diagnoses of CHF or diabetes, female sex, and age above the median of 63 years were all bivariate predictors of increased mortality. Age seems particularly noteworthy, with the mortality more than doubled in the patients over age 63 tality. Mortality was the same in patients undergoing a single-vessel PTCA as it was among those undergoing multivessel PTCA (excluding the intermediate group of single vessel with thrombolysis, which was usually used in cases of AMI).
Mortality for patients with an AMI as their principal diagnosis was 4.2% (n=4808) versus 0.8% (n=20 075) for the non-myocardial infarction group (P=.0001). AMI patients having PTCA on day 0 or 1 after admission (n=2581, 54% of AMI group) had a mortality of 5.5%, which was significantly higher than that of the AMI group treated later (2.6%, P=.0001).
Associated Coronary Artery Bypass Surgery
CABG was performed in 1241 patients or 5% of the overall group having PTCA. Most surgery was performed on the day of PTCA (61.7%), with 14.9% on the following day and 23.4% during the remainder of the admission. This distribution of the timing of surgery with respect to PTCA was not significantly different in the AMI, non-AMI, and early and late PTCA-treated AMI subgroups. Surgery was performed more often in the AMI group (n=341, 7.1%) than in the non-AMI group (n=900, 4.5%, P=.0001) ( Table 3 ). Among the AMI group, those having early PTCA on day 0 or 1 were more likely to have CABG than those having PTCA later during their hospitalization (8.4% early PTCA versus 5.5% late PTCA, P=.0001).
Mortality With Associated Coronary Artery Bypass Surgery
Overall, when patients who went on to have CABG were compared with those who did not have CABG, the mortality was consistently higher (P=.0001) for all subsets who had CABG (ie, AMI versus not and early PTCA versus not) by factors of twofold to 11-fold ( Table 3 ). The mortality of patients having CABG was 7.3% (91 of 1241) and was higher in the AMI group (12.0%) than in the non-AMI group (5.6%, P=.0001) ( Table 3 ). However, post-CABG mortality was not significantly different between the AMI patients who had had early PTCA (12.4%) versus those having PTCA later (11.4%).
Anatomic Location ofAcute Infarctions
Anatomically, of the 4808 AMI cases with AMI as the principal diagnosis, 32.5% were identified in the discharge abstract as electrocardiographically anterior, 45.6% were inferior or lateral, and 21.9% were subendocardial or undetermined. For AMI patients having PTCA on day 0 or 1 after admission, mortality was highest for the anterior group (anterior, 7.6%, 69 of 906 versus inferior, 4.2%, 51 of 1224 or other, 4.7%, 21 of 451; P<.05). Mortality was not significantly different among groups when they had PTCA after day 1. For both the anterior and inferior/lateral groups, 9.2% had CABG if they had day 0/1 PTCA, whereas the "other" category had CABG in only 5.1% of cases (P<.05). About 5% of each anatomic site had CABG when PTCA was performed on day 2 or later.
Predictors of Mortality and the Need for Coronary
Artery Bypass Surgery years. The presence of a secondary diagnosis of old myocardial infarction was associated with a lower mor-The results of the multiple logistic regression are shown in Tables 4 and 5 for predictors of CABG and PTCA indicates percutaneous transluminal coronary angioplasty; CABG, coronary artery bypass graft; AMI, acute myocardial infarction as the primary diagnosis; and no AMI, no acute myocardial infarction as the primary diagnosis. *P=.0001; tall categories of CABG versus non-CABG mortality. mortality, respectively. If patients in either the AMI or non-AMI group went on to have CABG surgery, there were no other significant predictors of mortality by logistic regression. Thus, Table 5 shows predictors of mortality only for patients who did not go on to CABG.
The logistic regression supports the importance of age in the non-AMI patients, with older age predicting both CABG and mortality.* Sex was significant in one of the four groups, with women at increased risk for mortality in only the non-AMI, non-CABG group. Non-Caucasian race was associated with increased mortality in the AMI, non-CABG group, but the opposite was true for the prediction of CABG in the AMI group. That is, Caucasians had a higher likelihood of CABG.
Timing of PTCA with respect to admission was statistically highly significant in essentially all of the *Quadratic terms (age squared) were included to improve the fit. groups, with early PTCA in the AMI group predicting an increased likelihood of both CABG and mortality. In the non-AMI group, later PTCA was associated with adverse outcomes. Diabetes was a predictor of CABG in the AMI group, and single-vessel PTCA, compared with a multivessel procedure, was a predictor of CABG in the non-AMI group.
Overall, these results were similar to those of bivariate analysis, with age and the timing of the procedure being consistent predictors of risk. Female sex was associated with an increased mortality only in the non-AMI, non-CABG subset when other factors were incorporated.
Institutional Caseload
The distribution of hospitals by institutional yearly volume is shown in Fig 1. There was a total of 128 hospitals with 1 or more PTCA patients. For this analysis we excluded 18 hospitals reporting 5 or fewer PTCAs (total 27 cases) as probable coding errors or that Table 6 and Figs 2 and 3. The likelihood of having either CABG and/or death (the combined end point) was significantly increased at the lower-volume institutions, as was the performance of CABG surgery when analyzed separately (both P<.001). This was the case for both the AMI and non-AMI groups-other patient risk adjustments were not performed for the institutional caseload analysis. Mortality was not significantly different between the low-and higher-volume institutions, although there was a nonsignificant trend in the AMI group. Also illustrated in Table 6 is the fact that a higher proportion of the patients treated at institutions with smaller volumes had a principal diagnosis of AMI (P=.0001).
Discussion
The principal strengths of administrative data are comprehensiveness and lack of reliance on voluntary reporting. Administrative data have a number of drawbacks, however. Clinical detail is limited -for example, whether or not CABG was performed emergently is not reported and thus our rates cannot be compared directly with some reports that include only emergency surgery but not elective surgery performed during the same admission. Similarly, because there is no specific coding for procedural complications, it is impossible to distinguish AMI that occurred as a procedural complication from AMI that occurred de novo on the days after PTCA. For this reason, we did not analyze AMIs reported as secondary diagnoses. However, patients presenting to the hospital with AMI should have this diagnosis coded as the principal diagnosis, and we analyzed this subset separately. If some of these patients had this diagnosis as a procedural complication, which was incorrectly coded as a principal diagnosis, the results reported for non-AMI cases will be biased toward better outcomes and those for AMI with worse outcomes, although the overall results would be unaffected. Also, the data reported reflect only the numbers of vessels on which PTCA was performed. Whether the patient had underlying single-, double-, or triple-vessel disease is not known. If a patient had a staged PTCA for multiple coronary stenoses and was admitted on two separate occasions, he would be counted twice (repeat PTCA during the same admission is reported and occurred uncommonly in 2.8% of cases). The reporting of this administrative data, required by law in the state of California for hospital licensure, has been assessed for its accuracy when reabstracted independently in 1990. For 1987 abstract data, the Office of Statewide Health Planning and Development visited 30 hospitals and reviewed the charts for 2596 discharges. These 30 hospitals were randomly selected from peer groups to ensure inclusion of all types of acute-care facilities. Demographic data as well as the 10 most common and 8 associated medical-surgical diagnosisrelated groups (DRGs) were selected for audit; the charts were reviewed and then recoded by the independent reviewer to assess the extent to which the original coding performed by the hospital had accurately re- flected the information in the chart. Of the 128 deaths reported by the hospitals, all were corroborated when reabstracted. Additionally, 2 deaths were discovered during chart reviews that had not been reported, ie, deaths were underreported by 1.6%. Principal diagnoses of chest pain and/or angina were reabstracted. Using all 5 digits of the ICD-9-CM codes, errors were detected in 18 of 264 cases (6.8%) -6 of these errors were shifts between the diagnosis of chest pain versus angina. For the diagnosis of CHF, 6 of 144 cases (4.2%) were incorrectly coded, 4 of them being recoded to a hypertension code. Other cardiovascular DRGs were not audited. Thus, principal diagnoses in cardiovascular disease appear to have been correctly coded in about 95% of cases. 17 In the 1989 California data, several features are of particular interest. Mortality, both overall and by subsets of AMI and non-AMI patients, was similar to or higher than most other series. The 0.8% mortality in the non-AMI group is similar to the 1.0% reported by the National Heart, Lung, and Blood Institute (NHLBI) Registry for 1985 to 1986, a series that excluded AMI within the previous 10 days and considered only first PTCA. 11 King and Talley8 reported a mortality of 0.36% for 1987 for elective PTCA at a large single institution. A recent report that summarized reported series that treated patients between 1980 and 1990 reported a range of mortalities from 0% to 2.0%, with a weighted average of 0.4%. 18 The California results are similar to or somewhat more favorable than the Medicare data reported for 1985, based largely on patients 65 years of age or older. In that report, for example, in-hospital mortality was 1.9% in patients not admitted for AMI and 4.4% for the overall group, whereas the overall mortality in California patients aged >63 years was 2.1%. 19 The recently reported experience in New York State for the first 6 months of 1991 appears to have a lower morbidity and mortality, although only about half as many patients (11.9%) in New York presented with an AMI, and that subset was not reported separately to allow direct comparison30 Whether the environment of New York State, with a relatively small number of institutions (n=31) performing PTCA, leads to improved outcomes is an important area for further exploration.
Among patients with AMI treated with PTCA, both with and without associated thrombolysis, mortality rates between 0% and 11.4% have been reported. 18 The Yearly PTCA Caseload California rate was 4.2%. Of note was the fact that this rate was highest for patients receiving PTCA on the first day of admission and that the rate declined for those receiving PTCA later during the course of admission but never became as low as that for the non-AMI cases. Logistic regression incorporating multiple variables also supported the importance of the timing of the procedure. The higher risk in the AMI group in the first 24 hours is the anticipated finding, ie, mortality generally is highest then for AMI patients not having PTCA. The observation that this higher risk continued throughout the peri-infarction period is in accord with other AMI trials using PTCA.21. 22 The lower mortalities for PTCA performed early during hospitalization in the non-AMI group presumably reflect the more elective nature of the procedures performed on the day of or early after admission.
The 5.0% incidence of CABG surgery during the same hospital admission is similar to that reported by the NHLBI Registry11 of 5.6% and similar to the figure of 3.4% reported for elective PTCA by King and Talley.8 Simpfendorfer et a19 reported a rate of 2.4% for emergency surgery in a single institution for 1986. A recent single-institution report notes surgery in 1.1% of cases in 1989 to 1991. 10 The New York experience was 2.4%. 20 The weighted average for reported series in the 1980s was 3.0%.18 Both the higher likelihood of requiring CABG in AMI patients and the higher mortality of CABG surgery performed in such circumstances are documented by the California data. The likelihood of having surgery was 58% greater in AMI patients over non-AMI patients (7.1 versus 4.5%). In some of the AMI cases, surgery may not have been an adverse outcome related to PTCA but may have been deemed appropriate in addition to PTCA. By logistic regression, the timing of the PTCA early in the AMI setting and late in the non-AMI case were the strongest predictors of CABG surgery (Table 4 ). The bypass surgery mortality was also high at 7.3% overall and substantially higher for patients with AMI at 12.0%. The 1989 California inpatient death rate for CABG patients without concomitant PTCA or valve surgery (n=21 371) during the same admission was 4.4% (1989 California discharge abstracts, unpublished). The relatively high CABG mortality in patients having PTCA is in keeping with the observation of Parsonnet et aP23 and Golding et al. 24 The data on the anatomic location of AMI is of particular interest with respect to CABG surgery. Among patients having PTCA on day 0/1 after AMI, a similar proportion of patients with both anterior and inferior/lateral infarction (9.2%) went on to bypass surgery. Thus, even the relatively lower-risk inferior infarction patients had as high a likelihood of receiving bypass surgery as did patients with anterior infarction.
The NHLBI Registry found patient-related predictors of acute vessel occlusion at the time of PTCA to be triple-vessel disease and acute coronary insufficiency.1 In that and other series, acute occlusion was the principal predictor of bypass surgery and death. Others have reported that female sex, diabetes, older age, left ventricular dysfunction, and hemodynamic instability were predictors of in-hospital mortality, surgery, or myocardial infarction. 3-11'20,2 In this series, older age, the presence of diabetes, female sex, and the timing of the PTCA but not multivessel procedures were associated with a higher mortality by bivariate analysis. CHF was similarly identified but may reflect heart failure developing after the complication of AMI and was not considered in the multivariate analysis. Old myocardial infarction was associated with a lower mortality, an unexpected finding presumably reflecting undercoding of this variable. The frequency of coding of the diagnosis of old myocardial infarction (a secondary diagnosis) in the California discharge data has been compared with its frequency in two other large clinical data sets in patients undergoing R-0% . %`V CABG surgery. It was coded only about one third as often as in the clinical data sets and thus appears to be underreported, whereas other secondary diagnoses such as diabetes were coded with similar frequencies. 26 Multiple logistic regression generally confirmed the bivariate analyses and illustrated that for patients going on to CABG, no other factors in the administrative data were predictors of death. The timing of PTCA was the strongest predictor of mortality in the AMI and non-AMI groups. Since many patients in this series were presumably undergoing repeat PTCA for restenosis from an earlier procedure, our results may be biased toward more favorable outcomes compared with other series in which only first cases were studied.18
In this series we report hospital charges only ( Table  1) ; professional fees are not coded and are thus not included. These hospital charges include the costs of associated bypass surgery in the 5% of cases in which that occurred. Nevertheless, these hospital charges are higher than other generally reported costs for PTCA.2728 If some patients had staged PTCA necessitating two or more admissions over a short period of time, the cost of revascularization for PTCA will be underestimated in that we are unable to follow patients over multiple hospitalizations. The comparable mean hospital charge figure for isolated CABG in 1989 in patients not having valve surgery or PTCA was $49 435 (SD, $38 337) (unpublished data from the California discharge abstracts) and serves as a benchmark for comparative purposes. Thus, PTCA charges averaged about 40% of those of isolated bypass surgery. Charges for both procedures are often discounted by negotiations between payers and hospitals, and our figures do not include this discounting, but the relative figure of 40% is unlikely to be altered substantially.
The data on institutional volume or caseload clearly demonstrate that a majority of California hospitals did not perform the recommended minimum volume of 200 cases. Although the mean number of PTCAs per institution was 225 per year, the 64 hospitals performing .200 cases per year averaged 109 PTCAs per institution. The lower-volume institutions treated a larger proportion of patients with AMI, probably reflecting the inability of AMI patients to travel to more distant, larger centers. However, the adverse outcomes of CABG surgery or the combined outcome of CABG surgery and/or death were increased in lower-volume institutions for AMI and non-AMI patients. These volume-outcome findings generally parallel the adverse outcomes reported for lower-volume CABG surgery programs. 15 One smaller study has not shown a relation between low institutional volume and adverse outcomes in a Medicare experience of PTCA patients.29 Higher CABG surgery rates for low-volume PTCA centers have been reported in a survey of 89 cardiac surgery programs.30 A more detailed analysis of the relation between institutional volumes, risk-adjusted outcomes, and hospital charges will be the subject of another report.
Summary
This study has shown that PTCA was performed more often than isolated CABG surgery in the state of California and that hospital charges averaged about 40% of those of isolated CABG surgery. The overall mortality of PTCA was 1.4% and was threefold higher in patients with AMI as the principal diagnosis. Five percent of PTCA patients went on to CABG surgery during the same admission, with a relatively high overall mortality of 7.3%. AMI patients going on to bypass surgery had an even higher mortality of 12.0%. This mortality and the need for CABG surgery are higher than that generally reported in the literature. Most hospitals did not perform the recommended minimum PTCA caseload in 1989. The need for CABG surgery and a combined end point of CABG surgery and/or death were increased at lower-volume institutions, although mortality alone was not.
